Jun, S. Y., Jung, G. M., Yoon, S. J., Choi, Y., Koh, W. S., Moon, K. S., & Kang, S. H. (2014). Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient. American Society for Microbiology.
Citação norma ChicagoJun, Soo Youn, Gi Mo Jung, Seong Jun Yoon, Yun-Jaie Choi, Woo Suk Koh, Kyoung Sik Moon, and Sang Hyeon Kang. Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 As a Pharmaceutical Ingredient. American Society for Microbiology, 2014.
Citação norma MLAJun, Soo Youn, et al. Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 As a Pharmaceutical Ingredient. American Society for Microbiology, 2014.